In his presentation at Ending Age-Related Diseases 2020, investor Sergey Young discussed the potential of a trillion-dollar market, proactive versus reactive medicine, demographic changes throughout the world, technology integration, the potential of regenerative medicine, the role of capital in rejuvenation biotechnology, and many other related topics.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Journal Club returns live to our Facebook channel on June 29th at noon Eastern Time with Dr. Oliver Medvedik. This month, we are taking a look at rapamycin, a drug that […]
In the final episode of X10’s overpopulation series, Nicola discusses why it would be enormously unethical to stop the progress of life extension to hope to stop overpopulation. Script Throughout the past […]
Write a comment: